799 related articles for article (PubMed ID: 11067888)
1. Cutting edge: TLR2-deficient and MyD88-deficient mice are highly susceptible to Staphylococcus aureus infection.
Takeuchi O; Hoshino K; Akira S
J Immunol; 2000 Nov; 165(10):5392-6. PubMed ID: 11067888
[TBL] [Abstract][Full Text] [Related]
2. Mice lacking myeloid differentiation factor 88 display profound defects in host resistance and immune responses to Mycobacterium avium infection not exhibited by Toll-like receptor 2 (TLR2)- and TLR4-deficient animals.
Feng CG; Scanga CA; Collazo-Custodio CM; Cheever AW; Hieny S; Caspar P; Sher A
J Immunol; 2003 Nov; 171(9):4758-64. PubMed ID: 14568952
[TBL] [Abstract][Full Text] [Related]
3. Impaired production of proinflammatory cytokines and host resistance to acute infection with Trypanosoma cruzi in mice lacking functional myeloid differentiation factor 88.
Campos MA; Closel M; Valente EP; Cardoso JE; Akira S; Alvarez-Leite JI; Ropert C; Gazzinelli RT
J Immunol; 2004 Feb; 172(3):1711-8. PubMed ID: 14734753
[TBL] [Abstract][Full Text] [Related]
4. Heat-killed Brucella abortus induces TNF and IL-12p40 by distinct MyD88-dependent pathways: TNF, unlike IL-12p40 secretion, is Toll-like receptor 2 dependent.
Huang LY; Aliberti J; Leifer CA; Segal DM; Sher A; Golenbock DT; Golding B
J Immunol; 2003 Aug; 171(3):1441-6. PubMed ID: 12874236
[TBL] [Abstract][Full Text] [Related]
5. MyD88-dependent but Toll-like receptor 2-independent innate immunity to Listeria: no role for either in macrophage listericidal activity.
Edelson BT; Unanue ER
J Immunol; 2002 Oct; 169(7):3869-75. PubMed ID: 12244184
[TBL] [Abstract][Full Text] [Related]
6. Dual role of TLR2 and myeloid differentiation factor 88 in a mouse model of invasive group B streptococcal disease.
Mancuso G; Midiri A; Beninati C; Biondo C; Galbo R; Akira S; Henneke P; Golenbock D; Teti G
J Immunol; 2004 May; 172(10):6324-9. PubMed ID: 15128822
[TBL] [Abstract][Full Text] [Related]
7. TLR2 as an essential molecule for protective immunity against Toxoplasma gondii infection.
Mun HS; Aosai F; Norose K; Chen M; Piao LX; Takeuchi O; Akira S; Ishikura H; Yano A
Int Immunol; 2003 Sep; 15(9):1081-7. PubMed ID: 12917260
[TBL] [Abstract][Full Text] [Related]
8. Cutting edge: MyD88 is required for resistance to Toxoplasma gondii infection and regulates parasite-induced IL-12 production by dendritic cells.
Scanga CA; Aliberti J; Jankovic D; Tilloy F; Bennouna S; Denkers EY; Medzhitov R; Sher A
J Immunol; 2002 Jun; 168(12):5997-6001. PubMed ID: 12055206
[TBL] [Abstract][Full Text] [Related]
9. Toll-like receptor 4 and Toll-IL-1 receptor domain-containing adapter protein (TIRAP)/myeloid differentiation protein 88 adapter-like (Mal) contribute to maximal IL-6 expression in macrophages.
Schilling D; Thomas K; Nixdorff K; Vogel SN; Fenton MJ
J Immunol; 2002 Nov; 169(10):5874-80. PubMed ID: 12421970
[TBL] [Abstract][Full Text] [Related]
10. Endotoxin-induced maturation of MyD88-deficient dendritic cells.
Kaisho T; Takeuchi O; Kawai T; Hoshino K; Akira S
J Immunol; 2001 May; 166(9):5688-94. PubMed ID: 11313410
[TBL] [Abstract][Full Text] [Related]
11. Cutting edge: myeloid differentiation factor 88 is essential for pulmonary host defense against Pseudomonas aeruginosa but not Staphylococcus aureus.
Skerrett SJ; Liggitt HD; Hajjar AM; Wilson CB
J Immunol; 2004 Mar; 172(6):3377-81. PubMed ID: 15004134
[TBL] [Abstract][Full Text] [Related]
12. Toll-like receptor 2 pathway drives streptococcal cell wall-induced joint inflammation: critical role of myeloid differentiation factor 88.
Joosten LA; Koenders MI; Smeets RL; Heuvelmans-Jacobs M; Helsen MM; Takeda K; Akira S; Lubberts E; van de Loo FA; van den Berg WB
J Immunol; 2003 Dec; 171(11):6145-53. PubMed ID: 14634130
[TBL] [Abstract][Full Text] [Related]
13. Differential contribution of Toll-like receptors 4 and 2 to the cytokine response to Salmonella enterica serovar Typhimurium and Staphylococcus aureus in mice.
Lembo A; Kalis C; Kirschning CJ; Mitolo V; Jirillo E; Wagner H; Galanos C; Freudenberg MA
Infect Immun; 2003 Oct; 71(10):6058-62. PubMed ID: 14500530
[TBL] [Abstract][Full Text] [Related]
14. Cutting edge: preferentially the R-stereoisomer of the mycoplasmal lipopeptide macrophage-activating lipopeptide-2 activates immune cells through a toll-like receptor 2- and MyD88-dependent signaling pathway.
Takeuchi O; Kaufmann A; Grote K; Kawai T; Hoshino K; Morr M; Mühlradt PF; Akira S
J Immunol; 2000 Jan; 164(2):554-7. PubMed ID: 10623793
[TBL] [Abstract][Full Text] [Related]
15. Critical roles of myeloid differentiation factor 88-dependent proinflammatory cytokine release in early phase clearance of Listeria monocytogenes in mice.
Seki E; Tsutsui H; Tsuji NM; Hayashi N; Adachi K; Nakano H; Futatsugi-Yumikura S; Takeuchi O; Hoshino K; Akira S; Fujimoto J; Nakanishi K
J Immunol; 2002 Oct; 169(7):3863-8. PubMed ID: 12244183
[TBL] [Abstract][Full Text] [Related]
16. Innate immune responses to Rhodococcus equi.
Darrah PA; Monaco MC; Jain S; Hondalus MK; Golenbock DT; Mosser DM
J Immunol; 2004 Aug; 173(3):1914-24. PubMed ID: 15265925
[TBL] [Abstract][Full Text] [Related]
17. Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components.
Takeuchi O; Hoshino K; Kawai T; Sanjo H; Takada H; Ogawa T; Takeda K; Akira S
Immunity; 1999 Oct; 11(4):443-51. PubMed ID: 10549626
[TBL] [Abstract][Full Text] [Related]
18. Toll-like receptor 2 (TLR2)-dependent-positive and TLR2-independent-negative regulation of proinflammatory cytokines by mycobacterial lipomannans.
Quesniaux VJ; Nicolle DM; Torres D; Kremer L; Guérardel Y; Nigou J; Puzo G; Erard F; Ryffel B
J Immunol; 2004 Apr; 172(7):4425-34. PubMed ID: 15034058
[TBL] [Abstract][Full Text] [Related]
19. The contribution of the Toll-like/IL-1 receptor superfamily to innate and adaptive immunity to fungal pathogens in vivo.
Bellocchio S; Montagnoli C; Bozza S; Gaziano R; Rossi G; Mambula SS; Vecchi A; Mantovani A; Levitz SM; Romani L
J Immunol; 2004 Mar; 172(5):3059-69. PubMed ID: 14978111
[TBL] [Abstract][Full Text] [Related]
20. Toll-like receptor-2, but not Toll-like receptor-4, is essential for development of oviduct pathology in chlamydial genital tract infection.
Darville T; O'Neill JM; Andrews CW; Nagarajan UM; Stahl L; Ojcius DM
J Immunol; 2003 Dec; 171(11):6187-97. PubMed ID: 14634135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
